Trial Profile
A Randomized, Placebo-Controlled Trial of Alendronate in the Treatment of Polyostotic Fibrous Dysplasia and the McCune-Albright Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary)
- Indications Developmental bone diseases
- Focus Therapeutic Use
- 16 Oct 2015 New trial record